camptothecin has been researched along with gw9662 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Bamforth, S; Behzadpoor, D; Cregan, S; Gonzalez, YR; Park, DS; Slack, RS; Zhang, Y | 1 |
Fujita, M; Koma, H; Nakamura, T; Okamura, N; Yagami, T; Yamamori, M; Yamamoto, Y | 1 |
4 other study(ies) available for camptothecin and gw9662
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.
Topics: Anilides; Animals; Camptothecin; Caspases; Cell Death; Cells, Cultured; Cerebral Cortex; Cytochromes c; DNA Damage; DNA-Binding Proteins; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Immunoprecipitation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; PPAR gamma; Repressor Proteins; Signal Transduction; Thiazolidinediones; Time Factors; Trans-Activators; Transfection | 2008 |
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2 | 2011 |